Congenital Toxoplasmosis

Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)

Also Known As:

Toxoplasmosis, Congenital; Congenital Infection, Toxoplasma gondii; Congenital Toxoplasma Infections; Toxoplasma Infections, Congenital; Congenital Toxoplasma Infection; Congenital Toxoplasmoses; Fetal Toxoplasmoses; Fetal Toxoplasmosis; Infection, Congenital Toxoplasma; Infections, Congenital Toxoplasma; Prenatal Toxoplasmoses; Prenatal Toxoplasmosis; Toxoplasma Infection, Congenital; Toxoplasmoses, Congenital; Toxoplasmoses, Fetal; Toxoplasmoses, Prenatal; Congenital Toxoplasma gondii Infection; Toxoplasmosis, Fetal; Toxoplasmosis, Prenatal

Infections: 539155
- Parasitic Diseases: 4973
  - Protozoan Infections: 287
    - Coccidiosis: 1365
      - Toxoplasmosis: 4566
        Congenital Toxoplasmosis: 454
- Central Nervous System Infections: 1428
  - Central Nervous System Parasitic Infections: 3
    - Central Nervous System Protozoal Infections: 52
      - Congenital Toxoplasmosis: 454
Nervous System Diseases: 14737
- Central Nervous System Diseases: 4371
  - Central Nervous System Infections: 1428
    - Central Nervous System Parasitic Infections: 3
      - Central Nervous System Protozoal Infections: 52
        Congenital Toxoplasmosis: 454
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Diseases Newborn Infant: 271
  - Congenital Toxoplasmosis: 454

Zulmirene Cardoso Fonseca Selected Research

Zulmirene Cardoso Fonseca Research Topics

Disease

Drug/Important Bio-Agent (IBA)